Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Impact of Early Blast Clearance Following Induction Chemotherapy On the Outcome of Patients with Acute Myelod Leukemia Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Philipp le Coutre, MD, Gero Massenkeil, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2012) 120 (21): 1998.

https://doi.org/10.1182/blood.V120.21.1998.1998

Published: 2012

Journal Articles

Cross-Species Investigations Reveal Role, Mechanism and Predictive Power of Paracrine, Secondary Senescence in B-Cell Lymphoma Therapy

Jan R. Dörr, Maja Milanovic, Yong Yu, Julia Kase, Dido Lenze, Michael Hummel, Gunnar Dittmar, Bernd Dörken, Georg Lenz, Soyoung Lee, Clemens A Schmitt

Blood (2012) 120 (21): 3715.

https://doi.org/10.1182/blood.V120.21.3715.3715

Published: 2012

Journal Articles

Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Blood (2012) 120 (21): 548.

https://doi.org/10.1182/blood.V120.21.548.548

Published: 2012

Journal Articles

Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients

Jaspal S Kaeda, PhD, Christian Oberender, Daniel Neuman, Theo Kim, MD, Ken I Mills, PhD, Anna Serra, PhD, Philipp Hemmati, MD, Regina Schleede, Tim Overkamp, Frauke Ringel, PhD, Thomas Pretzsch, Seval Turkmen, MD, Michaela Schwarz, MD, Renate Arnold, MD, Bernd Dörken, MD, Philipp le Coutre, MD

Blood (2012) 120 (21): 1449.

https://doi.org/10.1182/blood.V120.21.1449.1449

Published: 2012

Journal Articles

Targeting Notch and Hedgehog Embryonic Signaling Pathways Has Potent Anti-Tumor Activity in Myeloma and Is Effective in Myeloma Bone Disease.

Rolf Schwarzer, Nicole Schünemann, David M Wong, Bjarne Bogen, Kurt Bommert, Bernd Dörken, MD, Rudolf Manz, Franziska Jundt, MD

Blood (2012) 120 (21): 2938.

https://doi.org/10.1182/blood.V120.21.2938.2938

Published: 2012

Journal Articles

NIH-Defined Graft-Versus-Host Disease in Patients with Acute Lymphoblastic Leukemia: Natural History, Prognostic Impact and Effect of Donor Lymphocyte Infusions

Theis H. Terwey, Tanja M. Le Duc, Philipp G. Hemmati, Lam G. Vuong, Peter Martus, Philipp D. le Coutre, MD, Bernd Dörken, Renate Arnold

Blood (2011) 118 (21): 4547.

https://doi.org/10.1182/blood.V118.21.4547.4547

Published: 2011

Journal Articles

Prognostic Impact of a Monosomal Karyotype on the Outcome of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Philipp G. Hemmati, Theis H. Terwey, Philipp D. le Coutre, MD, Christian Ziegler, Grzegorz Kofla, Gero Massenkeil, MD, Bernd Dörken, Renate Arnold

Blood (2011) 118 (21): 2028.

https://doi.org/10.1182/blood.V118.21.2028.2028

Published: 2011

Journal Articles

Increased MSI2 expression Is Associated with Aggressive CML and AML

Blood (2011) 118 (21): 2516.

https://doi.org/10.1182/blood.V118.21.2516.2516

Published: 2011

Journal Articles

Therapy-Inducible Senescence Activates Both Innate and Adaptive Immune Mechanisms That Control Lymphoma Growth In Vivo

Jan Dörr, Selina Keppler, Maja Milanovic, Simone Spieckermann, Peter Aichele, Bernd Dörken, Clemens A Schmitt

Blood (2011) 118 (21): 107.

https://doi.org/10.1182/blood.V118.21.107.107

Published: 2011

Journal Articles

Effects of NVP-BSK805, a Novel JAK2 Inhibitor, on BCR-ABL and JAK2 V617F Positive Cell Lines

Frauke Ringel, PhD, Jaspal S Kaeda, PhD, FRCPath, Michaela Schwarz, MD, Peggy Grille, Bernd Dörken, Philipp D. le Coutre, MD

Blood (2011) 118 (21): 5002.

https://doi.org/10.1182/blood.V118.21.5002.5002

Published: 2011

Journal Articles

Contrary Functions of NF-κB Signaling in Anti-Cancer Treatment Outcome

Julia Kase, Hua Jing, Jan R Dörr, Maja Milanovic, Dido Lenze, Michael Grau, Gregor Beuster, Sujuan Ji, Maurice Reimann, Peter Lenz, Michael Hummel, Bernd Dörken, Georg Lenz, Claus Scheidereit, Soyoung Lee, Clemens A Schmitt

Blood (2011) 118 (21): 1652.

https://doi.org/10.1182/blood.V118.21.1652.1652

Published: 2011

Journal Articles

High-Level Expression of Mastermind-Like 2 (MAML2) Contributes to Aberrant Activation of the NOTCH Signaling Pathway In Human Lymphomas

Karl Köchert, Stephan Kreher, Jon C Aster, MD, PhD, Motoo Kitagawa, Korinna Jöhrens, Ioannis Anagnostopoulos, Franziska Jundt, MD, PD, Harald Stein, MD, Martin Janz, MD, Bernd Dörken, MD, Stephan Mathas, MD

Blood (2010) 116 (21): 2685.

https://doi.org/10.1182/blood.V116.21.2685.2685

Published: 2010

Journal Articles

Therapy-Senescent Lymphoma Cells Bear Potentially Detrimental Stem-Cell Characteristics.

Maja Milanovic, Jan Dörr, Dido Lenze, Michael Hummel, Bernd Dörken, MD, Clemens Schmitt, MD

Blood (2010) 116 (21): 2836.

https://doi.org/10.1182/blood.V116.21.2836.2836

Published: 2010

Journal Articles

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Unn-Merete Fagerli, MD, PhD, Thorsten Stühmer, PhD, Toril Holien, Randi Utne Holt, PhD, Ove Bruland, PhD, Manik Chatterjee, MD, John Shaughnessy, Jr, PhD, Stephan Mathas, MD, Anders Sundan, MD, Ralf C Bargou, MD, Bernd Dörken, MD, Magne Borset, MD, PhD, Martin Janz, MD

Blood (2010) 116 (21): 1915.

https://doi.org/10.1182/blood.V116.21.1915.1915

Published: 2010

Journal Articles

Long-Term Follow-up of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Patients After Stem Cell Mobilisation Under Imatinib.

Theo D. Kim, MD, Michaela Schwarz, MD, Karl-Anton Kreuzer, MD, Jaspal Kaeda, PhD, Kamran Movassaghi, MD, Peggy Grille, Peter Daniel, MD, PhD, Bernd Dörken, Philipp le Coutre

Blood (2010) 116 (21): 3418.

https://doi.org/10.1182/blood.V116.21.3418.3418

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation for Secondary or Therapy-Related Acute Myeloid Leukemia or Myelodysplastic Syndrome with Poor-Risk Cytogenetics.

Philipp G. Hemmati, MD, Theis Terwey, MD, Philipp D. le Coutre, MD, Gero Massenkeil, MD, Lam G Vuong, MD, PhD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2010) 116 (21): 3470.

https://doi.org/10.1182/blood.V116.21.3470.3470

Published: 2010

Journal Articles

Anti-CD20 Immunotherapy Augments the Chemotherapy-Induced Senescence Response In Human Lymphoma Cells

J. Henry M. Däbritz, Yong Yu, Mathias T. Rosenfeldt, MD, Bernd Dörken, MD, Clemens A. Schmitt, MD

Blood (2010) 116 (21): 1827.

https://doi.org/10.1182/blood.V116.21.1827.1827

Published: 2010

Journal Articles

Natural History, Risk Factors and Prognostic Impact of Graft-Versus-Host Disease Classified According to the National Institute of Health Criteria in Patients Receiving Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Theis H Terwey, Arturo Vega-Ruiz, Philipp G. Hemmati, Peter Martus, Ekkehart Dietz, Lam G Vuong, Philipp D le Coutre, Bernd Dörken, Renate Arnold

Blood (2010) 116 (21): 899.

https://doi.org/10.1182/blood.V116.21.899.899

Published: 2010

Journal Articles

Loss of Therapy-Induced Senescence in Myc-Driven Lymphomas Compromises Treatment Outcome In Vivo.

Jan Dörr, Yong Yu, Christoph Loddenkemper, MD, PhD, Ulrich Keller, MD, Andreas Buck, Bernd Dörken, Clemens Schmitt, MD

Blood (2009) 114 (22): 1686.

https://doi.org/10.1182/blood.V114.22.1686.1686

Published: 2009

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Blood (2009) 114 (22): 100.

https://doi.org/10.1182/blood.V114.22.100.100

Published: 2009

NARROW

Impact of Early Blast Clearance Following Induction Chemotherapy On the Outcome of Patients with Acute Myelod Leukemia Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Cross-Species Investigations Reveal Role, Mechanism and Predictive Power of Paracrine, Secondary Senescence in B-Cell Lymphoma Therapy

Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients

Targeting Notch and Hedgehog Embryonic Signaling Pathways Has Potent Anti-Tumor Activity in Myeloma and Is Effective in Myeloma Bone Disease.

NIH-Defined Graft-Versus-Host Disease in Patients with Acute Lymphoblastic Leukemia: Natural History, Prognostic Impact and Effect of Donor Lymphocyte Infusions

Prognostic Impact of a Monosomal Karyotype on the Outcome of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Increased MSI2 expression Is Associated with Aggressive CML and AML

Therapy-Inducible Senescence Activates Both Innate and Adaptive Immune Mechanisms That Control Lymphoma Growth In Vivo

Effects of NVP-BSK805, a Novel JAK2 Inhibitor, on BCR-ABL and JAK2 V617F Positive Cell Lines

Contrary Functions of NF-κB Signaling in Anti-Cancer Treatment Outcome

High-Level Expression of Mastermind-Like 2 (MAML2) Contributes to Aberrant Activation of the NOTCH Signaling Pathway In Human Lymphomas

Therapy-Senescent Lymphoma Cells Bear Potentially Detrimental Stem-Cell Characteristics.

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Long-Term Follow-up of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Patients After Stem Cell Mobilisation Under Imatinib.

Allogeneic Stem Cell Transplantation for Secondary or Therapy-Related Acute Myeloid Leukemia or Myelodysplastic Syndrome with Poor-Risk Cytogenetics.

Anti-CD20 Immunotherapy Augments the Chemotherapy-Induced Senescence Response In Human Lymphoma Cells

Natural History, Risk Factors and Prognostic Impact of Graft-Versus-Host Disease Classified According to the National Institute of Health Criteria in Patients Receiving Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Loss of Therapy-Induced Senescence in Myc-Driven Lymphomas Compromises Treatment Outcome In Vivo.

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only